The juvenile laryngeal papillomatosis is the most frequent benign tumour of the larynx. Pathology of papillomatosis Sir Morrel MacKenzie describes papillomas as pharyngo-laryngeal lesions at a child, and the term of juvenile laryngeal papillomatosis has been introduced by Chevalier Jakson in The etiological agent is HPV types 6 and 11 and the section of the respiratory pathology of papillomatosis the most frequently infected is the squamocolumelar junction.
Juvenile laryngeal papillomatosis is a disease more frequent between 3 and 5 years, characterised by multiple relapses and exuberant growth at the pathology of papillomatosis of the laryngeal mucosa.
The annual costs of the treatment of this pathology of papillomatosis are over million USD. The evolution of the disease decreases the quality of the life of the patient and pathology of papillomatosis and death can occur during the disease.
Objectives: bringing new informations about the etiology, the diagnosis and the treatment of the disease for the specialties that deal with this pathology, especially paediatrics and otolaryngologists.
The evolution of the patients with laryngeal papillomatosis depends on the early diagnosis and the corresponding treatment. Material and method: using data from the literature of pathology of papillomatosis and the clinical experience in the ENT Clinic in Timisoara virusi papiloma present actualities in pathology of papillomatosis epidemiology, the diagnosis and the treatment in the juvenile laryngeal papillomatosis.
Conclusions: juvenile laryngeal papillomatosis is pathology of papillomatosis by the HPV types 6 and The pathology of papillomatosis follows two objectives: relapses and the reestablishment of the respiratory and phonatory function.